We performed temporal and thermal stability studies on SP3-07, a liquid-stabilized reference material for apolipoprotein (apo) B, selected during the previous phase of the International Federation of Clinical Chemistry project on standardization of apolipoprotein measurements. Results indicate that SP3-07 stored at -70#{176}C has the long-term stability required for a reference material. We assigned an accuracy-based apo B value of 1.22 gIL to SP3-07, using a nephelometric method that was calibrated with freshly isolated low-density lipoprotein for which the apo B mass value was determined by a standardized sodium dodecyl sulfate-Lowry procedure. Using a common protocol, the study participants transferred the assigned mass value from SP3-07 to the individual calibrators of the analytical systems and measured the apo B concentration of 20 
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covering a clinically relevant range of apo B values. The among-laboratory CV on these samples, analyzed by 25 analytical systems, ranged from 3.1% to 6.7%. These results demonstrate the tack of matrix effects of SP3-07 and its ability to provide accurate and comparable apo B values in a variety of immunochemical methods. On the basis of the outcome of these studies, the World Health Organization has endorsed SP3-07 as the International We report here our data on the stability of a new preparation of this reference material, labeled SP3-07; on the assignment of mass units based on using LDL of narrow-density range as the primary standard; and on the abifity of this material to produce comparable results for normolipidemic samples with a large range of ape B values, as analyzed by a variety of commonly used immunochemical methods.
MaterIals and Methods

Participants and Test Systems
We This same approach was used to assign the ape B mass value to Reference Material SP3-07. Thirty-eight replicate analyses were performed by using freshly isolated LDL as a calibrator; an additional 30 replicate analyses were performed by calibrating the immunenephelometric system with the fresh-frozen serum pool that had been used as interim reference material in the first part of the study.
In addition to SP3-07, three new fresh-frozen pools were also prepared for use as quality-control samples in the second part of the study. For the value assignment to these pools, we used SP3.07 to calibrate the immunoassay and used the previous frozen pools as quality controls. To monitor the stability of the Reference Material over time, we are using a lyophilized serum preparation (IFCC-CDC 491), prepared as previously described (13), as an in-house reference point.
Temporal and Thermal Stability of SP3-07
Aliquots of SP3-07 were stored at -70, -20,4, 20, and 37#{176}C. Once a month, samples were removed from the different storage conditions and analyzed. Monthly analysis of the aliquots stored at 37#{176}C was performed for 6 months, whereas the aliquots stored at other temperatures were analyzed for 20 months.
Study Protocol
We followed the same multistep protocol described in detail for ape A-I (13), i.e., first using the fresh-frozen pool as interim reference material and subsequently using the proposed International Reference Material SP3-07. 
Data Analysis
We computed the mean values, SD, and CV determined for each of the frozen serum samples for each step of the protocol. We computed by linear regression analysis the Pearson product-moment correlation coefficient (r) between the assigned value and the mean measured value for each of the 50 or the 20 We also computed the assay CV for each sample from two replicate analyses performed on two separate days and computed the average of the CVs for both the 50 and the 20 samples for each system.
Results
Value Assignment
Using the approach described in Materials and Methods, we transferred an accuracy-based ape B value from freshly isolated LDL to three fresh-frozen serum pools designated Green 5, Blue 5, and Yellow 5. Using the mean of 38 replicate analyses performed at NWLRL and 24 replicate analyses performed at CDC, we determined that the ape B (mean ± SD) value of Green 5 was 0.63 ± 0.02 g/L, Blue 5 was 1.24 ± 0.03 gIL, and Yellow 5 was 1.37 ± 0.04 gIL (Table 1) . For the first part of the study, Yellow 5 was used as interim reference material, and Blue 5 and Green 5 were used as quality controls.
Because no significant differences were found in the ape B values obtained for SP3-07 by calibrating the nephelometric system with freshly purified LDL or Yellow 5, we used the mean of the 60 replicate analyses to assign to SP3-07 an ape B target value of 1.22 ± 0.02 g/L. Three new fresh-frozen serum pools-Red 5, Green 6, and Blue 6-were prepared as quality controls in the second part of the study with SP3-07. Using the mean of 30 replicate analyses, we assigned to ape B the value of 0.67 ± 0.02 gIL for Red 5, 1.04 ± 0.02 gIL for Green 6, and 1.36 ± 0.03 g/L for Blue 6 (mean ± SD, Table 1 ).
Stability Studies
The producer of the material, CDC, and NWLRL all performed stability studies with SP3-07. In temporal stability studies for SP3-07 stored at -70#{176}C, performed on a monthly basis at NWLRL, the observed changes in ape B values were well within the analytical variability The correlation coefficient between the assigned value and the mean value obtained for each sample was high for each of the systems, ranging from 0.977 to 0.999 ( Table 2 ). The average percent bias between the assigned and observed values ranged from -5.0% to 3.8%, with 19 of the 23 systems having an average percent bias of <3%. The average absolute percent bias ranged from 1.8% to 5.9%. Furthermore, the among-laboratory CV for 48 of the 50 samples was low, ranging from 3.1% to 7.6% (Fig. 1) . Only two samples, one with a low ape B concentration (0.44 g/L) and one with a high triglyceride content (3.02 g/L) had high among-method CVs of 15.1% and 9.5%, respectively.
TabI
To document uniformity of results after transfer of the ape B value from SP3-07 to the system calibrators, the participants analyzed 20 fresh-frozen samples obtained from normolipidemic donors, and performed the study with 25 systems (Table 3 ). The consensus value on each of the 20 samples was in excellent agreement with the assigned value, the average absolute bias between assigned and consensus value being 0.019 g/L; the linear regression analysis between the assigned and consensus values is described by the equation: consensus value = 0.98 x assigned value + 0.01 gIL (r = 0.996).
The average system CV computed from the four values obtained on each sample was low for all but two Table 2 ). The average percent bias between the assigned and observed values ranged from -5.3% to 4.7%. The average absolute bias ranged from 1.5% to 6.3% with 20 of 25 systems having an absolute bias of <5%. Furthermore, the among-laboratory CV on each of the 20 samples was low, ranging from 3.1% to 6.7% (Fig. 1) Participants calibrated each method by using an assigned value of 1.22 gIL for SP3-07 and then analyzed three fresh-frozen serum pools with low, medium, and high concentrations of ape B; they obtained low amongmethod CVs (5.0%, 3.6%, and 2.8% for the low-, medium-, and high-concentration pools, respectively). These among-method CVs indicated linearity of dose-response and the lack of a significant matrix effect of SP3-07 in the methods investigated.
The participants then transferred the mass value from SP3-07 to the calibrators of the different assay systems by use of a detailed protocol, and repeated the analyses of the three fresh-frozen serum pools by using the calibrators with the newly assigned values. For each pool, we observed low amongmethod CVs and mean values nearly identical to those assigned, thus confirming the accuracy of the value transfer.
To evaluate the analytical performance of the different instrument/reagent systems in terms of precision and comparability of results, we used an approach similar to that adopted by the Cholesterol Reference Method Laboratory Network (17, 19) . The study protocol involved measuring 50 individual fresh-frozen samples in the first part of the study with use of a freshfrozen serum pool as interim reference material and then measuring an additional 20 fresh-frozen samples after the transfer of an accuracy-based value from SP3-07 to the assay calibrators. Generally, as presented in Tables 2 and 3 , we found no significant differences between the performances of the different systems as evaluated with either the 50 or 20 fresh-frozen samples. However, the among-systems comparability of the data was better when evaluated with the 20 normolipidemic samples, as demonstrated by low CVs (Fig. 1, bottom) and with only one sample having a CV of 6.7%, whereas a CV of >6% was observed in 7 of the 50 samples evaluated in the earlier phase of the study (Fig. 1, top) . Of these seven samples, two had an ape B concentration <0.50 gIL and five had a triglyceride concentration >2.5 g/L. The major differences in ape B values in the samples with a high triglyceride content were found between methods that contained or did not contain detergent in the reaction buffer. After assigning the target value to the assay calibrators through the use of SP3-07, we arbitrarily established the following criteria for determining when a method could be considered standardized: r 0.975, overall imprecision 5%, and an average absolute bias of 6%. As Table 3 
